Rare and novel RUNX1 fusions in myeloid neoplasms: A single‐institute experience
- 20 October 2020
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 60 (2) , 100-107
Abstract
Chromosome translocations involving the RUNX1 gene at 21q22 are recurring abnormalities in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), that is, t(8;21) and t(3;21) and in B‐cell acute lymphoblastic leukemia with t(12;21). These translocations result in the fusion of RUNX1 with RUNX1T1, MECOM, and ETV6, respectively, and are implicated in leukemogenesis. Here we describe 10 rare RUNX1 fusion gene partners, including six novel fusions, in myeloid neoplasia. Comprehensive molecular testing revealed the partner genes and features of these fusions in all the tested patients, and detected various recurring myeloid related gene mutations in eight patients. In two patients, RUNX1 mutations were identified. Most of these fusions were detected in patients with high‐grade MDS and AML with a relatively short survival. Integration of conventional chromosome analysis, FISH testing and molecular genetic studies allow a comprehensive characterization of these rare RUNX1 fusions. Our study may help define myeloid neoplasms with rare and novel RUNX1 translocations and support appropriate patient management.Keywords
Funding Information
- The National Cancer Institute (P30 CA008748)
This publication has 20 references indexed in Scilit:
- Anchored multiplex PCR for targeted next-generation sequencingNature Medicine, 2014
- LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemiaMolecular Cancer, 2014
- Identification of a novel SEPT9-ABL1 fusion gene in a patient with T-cell prolymphocytic leukemiaLeukemia Research Reports, 2014
- RUNX family: Regulation and diversification of roles through interacting proteinsInternational Journal of Cancer, 2012
- MLL-SEPTIN gene fusions in hematological malignanciesBiological Chemistry, 2011
- RUNX1 Translocations and Fusion Genes in Malignant HemopathiesFuture Oncology, 2010
- RUNX Genes in Development and Cancer: Regulation of Viral Gene Expression and the Discovery of RUNX Family Genes2008
- AML1-FOG2 fusion protein in myelodysplasiaBlood, 2005
- AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AMLOncogene, 2001
- The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.Proceedings of the National Academy of Sciences, 1996